Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Qi deficiency syndrome is a conceptual diagnosis from traditional Chinese medicine describing a state in which the body's vital energy ("qi") is insufficient to maintain normal physiological functions, resulting in symptoms such as fatigue, weakness, shortness of breath, poor appetite, and weakened immunity. In TCM, Qi deficiency is understood as a root imbalance that can affect multiple organ systems, especially the spleen, lung, and kidney, leading to a broad spectrum of nonspecific symptoms[1][3][5]. In modern biomedical research, descriptors such as "Qi deficiency syndrome" are used in clinical stratification for metabolomics, genomics, and gut microbiota studies, but they do not correspond to a discrete molecular entity or "target protein"[2][4][7][8]. No scientific consensus or validation exists equating Qi deficiency with a specific biochemical or genetic defect, and the term is not used in the context of molecular medicine, pharmacology, or drug targeting. Summary of key issues: - "Qi deficiency syndrome" is a TCM diagnostic pattern, not a molecular or pharmacological target[1][3][5]. - While some biomedical studies have explored correlates (such as microRNA patterns[2], plasma metabolites[4], or gut microbiota changes[8]), these serve to describe patient groups, not to define a molecular target for drug action. - Therefore, this entry is considered incorrect as a therapeutic target according to standard biomedical and pharmacological classification; it should not be listed alongside receptors, enzymes, transporters, or other druggable biomolecules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Qi deficiency syndrome.